Macnis Pharmaceuticals Private Limited
Macnis Pharmaceuticals Private Limited is a Private Non-govt company company incorporated in 2021 and based in Delhi, India. It was founded by Abdul. Macnis Pharmaceuticals Private Limited operates in Pharmaceuticals & Chemicals (NIC 24290) with authorized capital of ₹1.00 L and paid-up capital of ₹1.00 L. For unknown, the company reported revenue of —. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Macnis Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 27 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +11d | filed |
| MGT-7 | FY2023-24 | 27 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 25 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Macnis Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 685489786 | Axis Bank Ltd(Bank) | ₹4.47 Cr | 27 Jan 2022 | Satisfied |
| 626833953 | HDFC Bank Ltd(Bank) | ₹13.00 Cr | 27 Jan 2021 | Open |
| 258071757 | HDFC Bank Ltd(Bank) | ₹15.87 Cr | 04 Jul 2021 | Open |
| 912673810 | HDFC Bank Ltd(Bank) | ₹8.44 Cr | 12 Mar 2021 | Satisfied |
Charge IDs, lenders & amounts for Macnis Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| unknown | — |
Detailed Financials
1 FYs| Line item | unknown |
|---|---|
| Income statement | |
| Revenue from operations | |
| Other income | |
| Total income | |
| Total expenses | |
| Profit before tax | |
| Profit / (Loss) after tax | |
| Balance sheet | |
| Equity / Net worth | |
| Borrowings | |
| Current liabilities | |
| Total liabilities | |
| Current assets | |
| Cash & equivalents | |
| Total assets | |
| Employees | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹5.59 Cr | +15.4% | +1.2% | +5.9% |
| Profit after Tax | ₹-8.21 L | -4.9% | +12.2% | +12.2% |
| Net Worth | ₹5.06 Cr | +17.7% | -5.7% | +9.0% |
| Employees | 265 | +3.4% | +5.2% | +20.5% |
Audited financials & ratios for Macnis Pharmaceuticals Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| unknown | — | — | — | — | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 2,23,10,469 | 71.87% |
| Institutional Investors | 2 | 18,85,670 | 6.07% |
| Public & Others | 63 | 68,47,330 | 22.06% |
Promoter, institutional & public holding for Macnis Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
98 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.